Recent studies indicate that semaglutide has the potential to lower the rate of psychiatric hospitalizations among patients with bipolar disorder. This drug, primarily used to manage diabetes and obesity, may have unexpected neurological benefits. Researchers suggest that GLP-1 signaling could help protect brain tissues from stress and inflammation, although similar effects weren’t seen with other GLP-1 drugs. More clinical trials are required to validate these exciting results.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.